Unknown PHASE4 INTERVENTIONAL 2-arm NCT01897805

A Trial to Evaluate Efficacy of Heart-protecting Musk Pill

A Randomized, Double-blind, Multi-centered, Placebo-controlled Trial to Examine Effects of Heart-protecting Musk Pill on Clinical Outcome in Patients With Chronic Stable Coronary Artery Disease

Sponsor: Shanghai Hutchison Pharmaceuticals Limited

Conditions Coronary Artery Disease

Interventions Heart-protecting Musk Pill Placebo

Updated 6 times since 2017 Last updated: Dec 17, 2014 Started: Jul 31, 2011 Primary completion: Jun 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01897805, this PHASE4 trial focuses on Coronary Artery Disease and remains ongoing. Sponsored by Shanghai Hutchison Pharmaceuticals Limited, it has been updated 6 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Dec 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Dec 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Hutchison Pharmaceuticals Limited

Data source: Shanghai Hutchison Pharmaceuticals Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anshan, China , Beijing, China , Changchun, China , Changde, China , Changsha, China , Chengdu, China , Chongqing, China , Dalian, China , Daqing, China , Fuzhou, China and 40 more locations